KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

BeOne Medicines (ONC) Return on Assets (2016 - 2025)

BeOne Medicines (ONC) has disclosed Return on Assets for 9 consecutive years, with 0.15% as the latest value for Q1 2024.

  • On a quarterly basis, Return on Assets rose 20.0% to 0.15% in Q1 2024 year-over-year; TTM through Mar 2024 was 0.15%, a 20.0% increase, with the full-year FY2024 number at 0.12%, up 5.0% from a year prior.
  • Return on Assets was 0.15% for Q1 2024 at BeOne Medicines, up from 0.17% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.15% in Q1 2024 to a low of 0.37% in Q1 2020.
  • A 5-year average of 0.28% and a median of 0.31% in 2020 define the central range for Return on Assets.
  • Biggest YoY gain for Return on Assets was 25bps in 2020; the steepest drop was -15bps in 2020.
  • BeOne Medicines' Return on Assets stood at 0.29% in 2020, then increased by 28bps to 0.21% in 2021, then tumbled by -53bps to 0.32% in 2022, then soared by 46bps to 0.17% in 2023, then increased by 14bps to 0.15% in 2024.
  • Per Business Quant, the three most recent readings for ONC's Return on Assets are 0.15% (Q1 2024), 0.17% (Q4 2023), and 0.17% (Q3 2023).